List of Excipients in API AMPHETAMINE SULFATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing AMPHETAMINE SULFATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | ANHYDROUS CITRIC ACID | |
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | CELLULOSE, MICROCRYSTALLINE | |
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | CROSPOVIDONE | |
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | DIBUTYL SEBACATE | |
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | |
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | ETHYLCELLULOSE | |
| Azurity Pharmaceuticals Inc | EVEKEO ODT | amphetamine sulfate | 24338-031 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing AMPHETAMINE SULFATE
Detailed excipient profiles for AMPHETAMINE SULFATE
Excipient focus: ANHYDROUS CITRIC ACID
AMPHETAMINE SULFATE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CELLULOSE, MICROCRYSTALLINE
AMPHETAMINE SULFATE drug variants containing CELLULOSE, MICROCRYSTALLINE
AMPHETAMINE SULFATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
AMPHETAMINE SULFATE drug variants containing CROSPOVIDONE
AMPHETAMINE SULFATE drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIBUTYL SEBACATE
AMPHETAMINE SULFATE drug variants containing DIBUTYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing DIBUTYL SEBACATE
Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
AMPHETAMINE SULFATE drug variants containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
Excipient focus: ETHYLCELLULOSE
AMPHETAMINE SULFATE drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 1
AMPHETAMINE SULFATE drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | amphetamine sulfate | 63629-2498 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
AMPHETAMINE SULFATE drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | amphetamine sulfate | 63629-2078 |
| Bryant Ranch Prepack | amphetamine sulfate | 72162-1088 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: MAGNESIUM STEARATE
AMPHETAMINE SULFATE drug variants containing MAGNESIUM STEARATE
AMPHETAMINE SULFATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALIC ACID
AMPHETAMINE SULFATE drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing MALIC ACID
Excipient focus: MANNITOL
AMPHETAMINE SULFATE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing MANNITOL
Excipient focus: POVIDONE K30
AMPHETAMINE SULFATE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | amphetamine sulfate | 57664-062 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
AMPHETAMINE SULFATE drug variants containing SILICON DIOXIDE
AMPHETAMINE SULFATE drug variants not containing SILICON DIOXIDE
Excipient focus: STEARIC ACID
AMPHETAMINE SULFATE drug variants containing STEARIC ACID
AMPHETAMINE SULFATE drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| Ingenus Pharmaceuticals LLC | amphetamine sulfate | 50742-651 |
| Ascend Laboratories LLC | amphetamine sulfate | 67877-710 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
AMPHETAMINE SULFATE drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | amphetamine sulfate | 24338-031 |
| >Company | >Ingredient | >NDC |
AMPHETAMINE SULFATE drug variants not containing SUCRALOSE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
